GRK2-Targeted Knockdown as Therapy for Multiple System Atrophy.

Miguel Lopez-CuinaPaul GuérinNathalie DutheilChristelle MartinThierry Leste LasserrePierre Olivier Fernagut Wassillios G Meissner Erwan Bezard

Published in: Movement disorders : official journal of the Movement Disorder Society (2023)

These data support GRK2 as a potential therapeutic target in MSA. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keyphrases

electronic health record
cancer therapy
big data
machine learning
drug delivery
artificial intelligence
risk assessment